Small Lymphocytic Lymphoma (SLL) Latest Advances

Diffuse Calcified Lymphadenopathy in Untreated Small Lymphocytic Lymphoma.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: January 20, 2026

Prolonged progression-free survival with zanubrutinib in relapsed/refractory CLL: an indirect treatment comparison versus other BTK inhibitors using multilevel network meta-regression.

Journal: Journal of medical economics

Published: January 19, 2026

Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US).

Journal: Expert review of hematology

Published: January 13, 2026

Expression of Type 2 Innate Lymphoid Cell and IL-9 and Other Related Cytokines in Chronic Lymphocytic Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: January 08, 2026

Beyond CKD-Associated Pruritus: Paraneoplastic Itch Revealing CLL/SLL in ESRD: A Case Report.

Journal: The American journal of case reports

Published: December 30, 2025

A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

Journal: Journal of medical economics

Published: December 27, 2025

Efficacy and long-term follow-up report of FCR regimen in the first-line treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 17, 2025

Updates in the management of newly diagnosed chronic lymphocytic leukemia.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

The role of MRD monitoring and options for CLL management in relapsed/refractory disease.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Real-world overall survival comparison between first-line Bruton tyrosine kinase inhibitors in treating chronic lymphocytic leukemia/small lymphocytic lymphoma: An analysis of Veterans Health Administration data.

Journal: Journal of managed care & specialty pharmacy

Published: December 03, 2025

Association of Galectin-9 Soluble Immune Checkpoint with Clinical Prognostic Markers in Patients with Chronic Lymphocytic Leukemia.

Journal: International journal of molecular sciences

Published: November 18, 2025

Ocular Adnexal Lymphoma of the Lacrimal Drainage Apparatus: Clinical Characteristics, Radiographic Features, and Management.

Journal: Ophthalmic plastic and reconstructive surgery

Published: November 18, 2025